Literature DB >> 20380524

Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells.

Hosam Zaghloul1, Walid El-Sherbiny.   

Abstract

PURPOSE: To investigate the problem of occult HCV & HBV infections in patients with persistently longstanding abnormal liver function test results of unknown etiology and to investigate occult HCV in patients with sustained virological response (SVR).
METHODS: The study included two groups; first group included 40 patients with persistently longstanding abnormal liver function test, in addition to 62 patients with history of hepatitis C who developed SVR. HCV RNA status was tested in serum by conventional RT-PCR and by real-time PCR in Peripheral Blood Mononuclear Cells (PBMCs). HBV DNA in PBMCs was done in first group only.
RESULTS: In first group, PCR in PBMCs was positive for HCV RNA in 4 patients with elevated liver enzymes and HBV DNA was positive in PBMCs in 3 patients. In patients with SVR, 7 patients were positive for HCV RNA in PBMCs.
CONCLUSIONS: Patients with long-standing abnormal results of liver-function tests with unknown etiology may have HCV RNA or HBV DNA in their PBMCs in the absence of anti-HCV antibodies, HBV markers, serum HBV DNA and serum HCV RNA.In Patients with SVR, HCV RNA in PBMCs is recommended to detect residual infection especially in those with high serum HCV RNA levels before treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20380524     DOI: 10.3109/08820131003605820

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  13 in total

1.  New perspectives in occult hepatitis C virus infection.

Authors:  Vicente Carreño; Javier Bartolomé; Inmaculada Castillo; Juan Antonio Quiroga
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

2.  Occult hepatitis C virus infection and its relevance in clinical practice.

Authors:  Tram Nq Pham; Tomasz I Michalak
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

Review 3.  An overview of occult hepatitis B virus infection.

Authors:  Zeinab Nabil Ahmed Said
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

Review 4.  Occult HCV Infection: The Current State of Knowledge.

Authors:  Mohammad Saeid Rezaee-Zavareh; Reza Hadi; Hamidreza Karimi-Sari; Mohammad Hossein Khosravi; Reza Ajudani; Fardin Dolatimehr; Mahdi Ramezani-Binabaj; Seyyed Mohammad Miri; Seyed Moayed Alavian
Journal:  Iran Red Crescent Med J       Date:  2015-11-29       Impact factor: 0.611

Review 5.  Seronegative hepatitis C virus infection.

Authors:  Justyna Kaźmierczak; Agnieszka Pawełczyk; Kamila Caraballo Cortes; Marek Radkowski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-11-09       Impact factor: 4.291

Review 6.  The place of immunotherapy in the management of HCV-induced vasculitis: an update.

Authors:  Laurent Chiche; Stanislas Bataille; Gilles Kaplanski; Noemie Jourde
Journal:  Clin Dev Immunol       Date:  2012-08-15

7.  Prevalence of occult hepatitis C virus in egyptian patients with chronic lymphoproliferative disorders.

Authors:  Samar Samir Youssef; Aml S Nasr; Taher El Zanaty; Rasha Sayed El Rawi; Mervat M Mattar
Journal:  Hepat Res Treat       Date:  2012-12-12

8.  Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis.

Authors:  Hossein Keyvani; Farah Bokharaei-Salim; Seyed Hamidreza Monavari; Maryam Esghaei; Mohssen Nassiri Toosi; Shahin Fakhim; Zohreh Azita Sadigh; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2013-08-05       Impact factor: 0.660

9.  Peripheral Blood Mononuclear Cell Gene Expression Remains Broadly Altered Years after Successful Interferon-Based Hepatitis C Virus Treatment.

Authors:  Paul Ravi Waldron; Mark Holodniy
Journal:  J Immunol Res       Date:  2015-10-19       Impact factor: 4.818

Review 10.  A New Twist to a Chronic HCV Infection: Occult Hepatitis C.

Authors:  Bashar M Attar; David Van Thiel
Journal:  Gastroenterol Res Pract       Date:  2015-06-24       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.